IRS Stock Analysis: IRSA Inversiones Y | NYSE
Real Estate Services | NYSE, USA | Market Cap: 1.061m USD | 12M Return: -19.4% | US4500473032 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.36M
Rev. Trend: 94.8%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality
IRSA Inversiones y Representaciones (IRS) is Argentina’s largest diversified real estate company, operating across shopping malls, premium offices, luxury hotels, and residential developments. The firm manages a portfolio of high-traffic assets, including iconic hospitality brands such as Llao Llao and Intercontinental, while maintaining a significant land bank for future urban expansion. Its business model focuses on long-term capital appreciation and recurring rental income from commercial leases.
The Argentine real estate sector often serves as a localized hedge against currency volatility, as high-end commercial leases are frequently indexed or denominated in USD equivalents. As a subsidiary of Cresud, IRSA integrates its physical retail presence with digital initiatives like the ¡appa! loyalty platform to drive consumer engagement across its shopping centers. Investors can evaluate the company’s underlying asset valuations and debt profile on ValueRay to better understand its market position.
Headquartered in Buenos Aires, the company operates as a vertically integrated developer, managing the entire lifecycle of a property from land acquisition and construction to facility management and eventual divestment. This model allows the firm to capture value during various stages of the Argentine economic cycle by shifting focus between rental income and asset sales.
- Argentine macroeconomic instability and inflation volatility impact real estate valuation and rental yields
- Shopping mall consumption levels drive primary revenue through variable lease agreements and services
- Significant exposure to Argentine Peso devaluation affects debt servicing and local currency earnings
- Strategic asset divestments and land reserve monetization influence short-term cash flow and liquidity
| Net Income: 195b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -3.46 > 1.0 |
| NWC/Revenue: 54.05% < 20% (prev -21.41%; Δ 75.46% < -1%) |
| CFO/TA 0.02 > 3% & CFO 113b > Net Income 195b |
| Net Debt (494b) to EBITDA (390b): 1.27 < 3 |
| Current Ratio: 1.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (8.37m) vs 12m ago -90.09% < -2% |
| Gross Margin: 59.96% > 18% (prev 33.79%; Δ 26.17% > 0.5%) |
| Asset Turnover: 17.77% > 50% (prev 20.34%; Δ -2.57% > 0%) |
| Interest Coverage Ratio: 4.13 > 6 (EBIT TTM 357b / Interest Expense TTM 86.4b) |
| A: 0.07 (Total Current Assets 761b - Total Current Liabilities 400b) / Total Assets 5009b |
| B: 0.09 (Retained Earnings 467b / Total Assets 5009b) |
| C: 0.09 (EBIT TTM 357b / Avg Total Assets 3755b) |
| D: 0.98 (Book Value of Equity 2403b / Total Liabilities 2460b) |
| Altman-Z'' = 2.44 = A |
| DSRI: 1.93 (Receivables 213b/83.7b, Revenue 667b/509b) |
| GMI: 0.56 (GM 33.79% / 59.96%) |
| AQI: 0.95 (AQ_t 0.83 / AQ_t-1 0.87) |
| SGI: 1.31 (Revenue 667b / 509b) |
| TATA: 0.02 (NI 195b - CFO 113b) / TA 5009b) |
| Beneish M = -2.46 (Cap -4..+1) = BBB |
As of November 22, 2026, the stock is trading at USD 10.67 with a total of 268,146 shares traded. Over the past week, the price has changed by -14.91%, over one month by -14.95%, over three months by -17.99% and over the past year by -19.41%.
Current recommended Stop Loss: 9.80 (which is 8.2% or 1.3 ATR below the current price).
IRSA Inversiones Y has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy IRS.
- StrongBuy: 1
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 21.9 | 105% |
Market Cap ARS = 1676b (1.06b USD * 1579.5 USD.ARS)
P/E Trailing = 7.2907
P/E Forward = 38.1679
P/S = 0.0015
P/B = 0.6818
P/EG = 2.7255
Revenue TTM = 667b ARS
EBIT TTM = 357b ARS
EBITDA TTM = 390b ARS
Long Term Debt = 851b ARS (from longTermDebt, last quarter)
Short Term Debt = 151b ARS (from shortTermDebt, last quarter)
Debt = 1023b ARS (from shortLongTermDebtTotal, last quarter) + Leases 13.3b
Net Debt = 494b ARS (calculated: Debt 1023b - CCE 529b)
Enterprise Value = 2170b ARS (1676b + Debt 1023b - CCE 529b)
Interest Coverage Ratio = 4.13 (Ebit TTM 357b / Interest Expense TTM 86.4b)
EV/FCF = 21.02x (Enterprise Value 2170b / FCF TTM 103b)
FCF Yield = 4.76% (FCF TTM 103b / Enterprise Value 2170b)
FCF Margin = 15.47% (FCF TTM 103b / Revenue TTM 667b)
Net Margin = 29.28% (Net Income TTM 195b / Revenue TTM 667b)
Gross Margin = 59.96% ((Revenue TTM 667b - Cost of Revenue TTM 267b) / Revenue TTM)
Gross Margin QoQ = 61.81% (prev 56.46%)
Tobins Q-Ratio = 0.43 (Enterprise Value 2170b / Total Assets 5009b)
Interest Expense / Debt = 8.45% (Interest Expense 86.4b / Debt 1023b)
Taxrate = 20.07% (54.1b / 270b)
NOPAT = 285b (EBIT 357b * (1 - 20.07%))
Current Ratio = 1.90 (Total Current Assets 761b / Total Current Liabilities 400b)
Debt / Equity = 0.43 (Debt 1023b / totalStockholderEquity, last quarter 2403b)
Debt / EBITDA = 1.27 (Net Debt 494b / EBITDA 390b)
Debt / FCF = 4.79 (Net Debt 494b / FCF TTM 103b)
Total Stockholder Equity = 2115b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.20% (Net Income 195b / Total Assets 5009b)
RoE = 9.24% (Net Income TTM 195b / Total Stockholder Equity 2115b)
RoCE = 12.03% (EBIT 357b / Capital Employed (Equity 2115b + L.T.Debt 851b))
RoIC = 6.03% (NOPAT 285b / Invested Capital 4726b)
WACC = 7.33% (E(1676b)/V(2699b) * Re(7.69%) + D(1023b)/V(2699b) * Rd(8.45%) * (1-Tc(0.20)))
Discount Rate = 7.69% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -60.10 | Cagr: -86.20%
[DCF] Terminal Value 73.10% ; FCFF base≈117b ; Y1≈103b ; Y5≈83.0b
[DCF] Fair Price = 9.91k (EV 1332b - Net Debt 494b = Equity 838b / Shares 84.6m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 94.77 | Revenue CAGR: 23.82% | SUE: 1.24 | # QB: 2
EPS current Quarter (2026-12-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2027-03-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2027-06-30): EPS=0.12 | Chg30d=-78.41% | Revisions=+25% | GrowthEPS=+0.0% | GrowthRev=-12.6%
EPS next Year (2028-06-30): EPS=0.26 | Chg30d=-58.86% | Revisions=+0% | GrowthEPS=+114.1% | GrowthRev=+7.1%